SelectQuote, Inc. Q4 2025 Earnings Recap

SLQT Q4 2025 August 21, 2025

Get alerts when SLQT reports next quarter

SelectQuote reported a robust fiscal 2025, achieving consolidated revenue growth of 16% to $1.5 billion, driven primarily by a 55% increase in its Healthcare Services business, SelectRx.

Earnings Per Share Beat

$-0.17 vs $-0.18 est.

+5.6% surprise

Revenue Beat

345102000 vs 334177330 est.

+3.3% surprise

Market Reaction

1-Day +41.53%

5-Day +37.16%

30-Day +14.21%

See SLQT alongside your other holdings

Add to your portfolio — free

Key Takeaways

Adjusted EBITDA reached $126 million, maintaining an EBITDA margin of 8%, despite significant incremental revenue from lower-margin healthcare services.
Senior Medicare Advantage business demonstrated strong productivity, with a 24% increase in agent performance amid a challenging industry environment.
Revenue to customer acquisition cost ratio improved from 1.7x to 6.1x over the past three years, indicating enhanced operational efficiency.
SelectRx revenue grew to $743 million, with an expectation of increased margins and cash flow contributions in fiscal 2026 as membership scales.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit SLQT on AllInvestView.

Next Q2 2026